Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease – implications for the clinical utility of the EASL NIT guideline

TY - JOUR

T1 - Poor performance of FIB-4 in elderly individuals at risk for chronic liver disease – implications for the clinical utility of the EASL NIT guideline

AU - van Kleef, Laurens A.

AU - Sonneveld, Milan J.

AU - de Man, Robert A.

AU - de Knegt, Robert J.

N1 - Funding Information: MS has received speaker's fees and research support from Fujirebio and received grants from Gilead. RdK is a speaker for Echosens, consultant for AbbVie and received grants from Abbvie, Gilead and Janssen. The remaining authors reported no relevant conflicts. Funding Information: The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam , Netherlands Organization for the Health Research and Development (ZonMw), the Research institute for Diseases in the Elderly (Ride), the Ministry of Education, Culture and Science , the Ministry for Health, Welfare and Sports , the European Commission (DG XII) and the Municipality of Rotterdam . Financial support was also provided by the Foundation for Liver and Gastrointestinal Research , Rotterdam, the Netherlands. The funding sources did not influence study design, data collection, analysis and interpretation of the data, nor the writing of the report and decision to submit for publication.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85116816861

U2 - 10.1016/j.jhep.2021.08.017

DO - 10.1016/j.jhep.2021.08.017

M3 - Article

C2 - 34461208

AN - SCOPUS:85116816861

SN - 0168-8278

VL - 76

SP - 245

EP - 246

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 1

ER -